Funded Tech Companies
Alpha-9 Theranostics
Wondering who backed Alpha-9 Theranostics? BVF Partners, Frazier Healthcare Partners and Nextech Invest invested in this healthcare services company.
Company Overview
Company Name
Alpha-9 Theranostics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
131 Dartmouth St, 3rd Fl
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Alpha-9 Theranostics is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to tumor sites while minimizing off-target effects. Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/14/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Hirsch
Chief Financial Officer
Matthias Jaffe
Chief Operating Officer
Alison Fleming
Company Investors
- BVF Partners
- Frazier Healthcare Partners
- Nextech Invest (Melissa McCracken)
- Longitude Capital Management
- Samsara BioCapital
- Quark Venture
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs